AI assistant
ERYTECH Pharma S.A. — Regulatory Filings 2015
Apr 9, 2015
1295_dva_2015-04-09_7eec0dcc-4ee5-4858-953e-e3efdb05968e.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Information related to total number of voting rights and shares composing the share capital March 2015
Article 223-16 of general regulation of french Autorité des Marchés Financiers Lyon - France
Listing market : Euronext Paris from Euronext Market segment : segment B ISIN Code : FR0011471135 website : www.erytech.com
| Date | Total of shares composing the share capital |
Total of brut(1) voting rights |
Total of net(2) voting rights |
|---|---|---|---|
| 31 January 2015 | 6 882 761 | 8 090 321 | 8 085 071 |
| 28 February 2015 | 6 886 441(3) | 8 094 001 | 8 092 501 |
| 31 March 2015 | 6 886 941(3) | 8 094 301 | 8 091 801 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
(3) The total of shares composing the share capital has increased with the exercise of securities giving access to the share capital. Capital increase will be recorded by delegation during the next Board of Directors.